series-a
Stage
1
Investors
About
Pathway Therapeutics is a drug discovery company focused on developing inhibitors of PI3-kinase for the treatment of cancer and inflammatory diseases.
Explore Pathway Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.